The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsis
about
Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapySepsis in the severely immunocompromised patient.Sepsis: frontiers in supportive care, organisation and research.Proposed mechanisms for oligonucleotide IMT504 induced diabetes reversion in a mouse model of immunodependent diabetes.
P2860
The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsis
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The novel immunotherapeutic ol ...... ruginosa bacteremia and sepsis
@ast
The novel immunotherapeutic ol ...... ruginosa bacteremia and sepsis
@en
type
label
The novel immunotherapeutic ol ...... ruginosa bacteremia and sepsis
@ast
The novel immunotherapeutic ol ...... ruginosa bacteremia and sepsis
@en
prefLabel
The novel immunotherapeutic ol ...... ruginosa bacteremia and sepsis
@ast
The novel immunotherapeutic ol ...... ruginosa bacteremia and sepsis
@en
P2093
P2860
P356
P1476
The novel immunotherapeutic ol ...... ruginosa bacteremia and sepsis
@en
P2093
Abdullah Chahin
David L Horn
David V Jobes
John E Palardy
Jorge Zorzopulos
Michelle Yamamoto
Nicholas Parejo
Steven M Opal
Yazan Migdady
P2860
P304
P356
10.1128/AAC.03923-14
P407
P577
2014-12-15T00:00:00Z